Mario Morotti

University of Oxford, Oxford, United Kingdom 
"Mario Morotti"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Tantari M, Bogliolo S, Morotti M, et al. (2022) Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study. Cancers. 14
Valenti G, Vitagliano A, Morotti M, et al. (2021) Risks factors for anastomotic leakage in advanced ovarian cancer: A systematic review and meta-analysis. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 269: 3-15
Cocozza G, Garofalo S, Morotti M, et al. (2021) The feeding behaviour of ALS mouse models is modulated by the Ca -activated KCa3.1 channels. British Journal of Pharmacology
Addley S, Morotti M, Pinelli C, et al. (2021) Transdiaphragmatic resection of enlarged cardiophrenic lymph node during interval debulking surgery for advanced ovarian cancer. Gynecologic Oncology Reports. 37: 100807
Bruand M, Barras D, Mina M, et al. (2021) Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING. Cell Reports. 36: 109412
Sarivalasis A, Morotti M, Mulvey A, et al. (2021) Cell therapies in ovarian cancer. Therapeutic Advances in Medical Oncology. 13: 17588359211008399
Artibani M, Masuda K, Hu Z, et al. (2021) Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells. Jci Insight
Morotti M, Albukhari A, Alsaadi A, et al. (2021) Promises and challenges of adoptive T-cell therapies for solid tumours. British Journal of Cancer
Santana Gonzalez L, Rota IA, Artibani M, et al. (2021) Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct. Frontiers in Cell and Developmental Biology. 9: 605301
Morotti M, Soleymani Majd H, Casarin J, et al. (2021) Histomolecular features of high-grade endometrial cancers. Minerva Medica. 112: 20-30
See more...